Bio-Rad Laboratories (NYSE:BIO) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Bio-Rad Laboratories beat estimated earnings by 45.29%, reporting an EPS of $4.94 versus an estimate of $3.4.
Revenue was down $26.73 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.36 which was followed by a 0.74% increase in the share price the next day.
Here's a look at Bio-Rad Laboratories's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 2.85 | 2.44 | 2.66 | 3 |
| EPS Actual | 3.21 | 3.71 | 3.54 | 5.21 |
| Revenue Estimate | 731.98M | 661.87M | 631.78M | 660.98M |
| Revenue Actual | 732.77M | 715.20M | 715.93M | 726.80M |
To track all earnings releases for Bio-Rad Laboratories visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
